Harvey Stober, senior equity analyst and correspondent at CNBC, explains why this healthcare company could benefit from ...

Across the recent three months, 4 analysts have shared their insights on Health Catalyst (NASDAQ:HCAT), expressing a variety of opinions spanning from bullish to bearish. The following table provides ...

As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the data analytics industry, ...

In the last three months, 5 analysts have published ratings on Evolent Health (NYSE:EVH), offering a diverse range of perspectives from bullish to bearish. The table below offers a condensed view of ...

The Health Information Management field is constantly evolving. Industry changes are vast and vary from the implementation of electronic health records to an increased focus on protected health ...

During the last three months, 7 analysts shared their evaluations of Agilon Health (NYSE:AGL), revealing diverse outlooks from bullish to bearish. In the table below, you'll find a summary of their ...

May 13 (Reuters) - U.S. health insurers' strong first-quarter results signaled more stable medical costs after prolonged pressure, but Wall Street analysts want to see another similar quarter before ...